Director, Global Market Access & Health Economics

Role Overview:

The Director, Global Market Access & Health Economics will build the strategy, infrastructure, and institutional relationships from the ground up across four markets: the United States, DACH, United Kingdom, and Ireland.

In the US, the role inherits an active NTAP (New Technology Add-on Payment) landscape and is responsible for maximising the value of that recognition — ensuring account-level billing adherence, building the evidentiary and financial record, and developing the long-term CMS engagement strategy to support durable reimbursement pathways including DRG and ICD-10 code strategy. In EU, UK, and Ireland, the role will assess each market’s reimbursement architecture independently and develop market-specific access strategies. This role reports to the VP, Global Marketing and works in close partnership with Clinical, Medical Affairs, Regulatory (CMRA), and the commercial field teams. It is an individual contributor role with the expectation of building out a function as the company scales.

Key Responsibilities:

US Reimbursement Strategy & CMS Engagement

• Lead the development of the US reimbursement roadmap, including the evidentiary and economic case for DRG payment optimisation and ICD-10 procedure code strategy.
• Partner with CMRA to synthesise clinical evidence, economic data, and crosswalk analysis in support of CMS submissions and advocacy.
• Drive account-level adherence to correct NTAP billing practices to build a robust utilisation record in support of long-term reimbursement strategy.
• Monitor IPPS rulemaking cycles and MedPAC activity; develop proactive positioning and response strategies.
• Serve as the internal expert on US coding, coverage, and payment — supporting the field sales team and hospital customers on reimbursement questions.

EU, UK & Ireland Market Access

• Develop and execute market access strategies for the EU, UK (NHS England), and Ireland (HSE), navigating the distinct HTA and reimbursement frameworks in each market independently.
• Identify reimbursement barriers and accelerants at country level; build and maintain a clear market access roadmap for each region.
• Manage relationships with external consulting resources to supplement in-house expertise where required.
• Collaborate with the EU commercial team to translate access strategies into field-deployable tools and account-level support.

Health Economics Infrastructure

• Build the company’s global health economic value proposition from the ground up — including budget impact models, cost-effectiveness frameworks, and payer-facing value dossiers.
• Develop economic narratives that quantify the cost burden of post-stroke dysphagia and the financial value of Phagenyx intervention for hospital C-suite and payer audiences.
• Develop and maintain a global value-evidence plan linking reimbursement objectives to clinical evidence, claims data, health-economic analyses and publication priorities.
• Partner with Marketing and Medical Affairs to ensure health economic claims are evidence-based, regionally appropriate, and commercially deployable.

Policy development

• Identify and pursue opportunities to incorporate PES into national stroke pathways, clinical standards, certification frameworks, and commissioning specifications.

Field & Commercial Enablement

• Act as the primary reimbursement resource for the US and EU commercial teams — providing education, tools, and live support on coding, coverage, and payer navigation.
• Develop and maintain reimbursement education materials for hospital customers, practice administrators, and clinical staff.
• Lead periodic customer business reviews incorporating payer and financial data relevant to account-level access and utilisation.

Cross-functional Partnership

• Serve as a strategic partner to CMRA on evidence development priorities that support reimbursement and market access goals.
• Align with Clinical/Medical Affairs on publication strategy where health economic evidence is a key output.
• Contribute to SLT-level planning and commercial strategy with a market access lens.

Essential Experience:

• 8+ years of market access, health economics, or reimbursement experience in medical devices, pharmaceutical, or biotechnology.
• Deep, demonstrable fluency in US CMS billing and coding infrastructure — including DRG payment logic, IPPS rulemaking, NTAP mechanics, and ICD-10/CPT code strategy.
• Proven experience building the evidentiary and financial case for coverage expansion or new payment recognition with CMS.
• Ability to navigate complex, multi-stakeholder regulatory and payer environments independently.
• Strong health economics foundation — able to build and present budget impact models and value dossiers credibly to payer and C-suite audiences.
• Experience working closely with field sales teams as a reimbursement resource and commercial partner.
• Exceptional written and verbal communication skills; capable of translating complex reimbursement concepts for clinical, administrative, and executive audiences.
• Comfort operating in a start-up or commercial-stage environment — building from scratch, managing ambiguity, and prioritising across competing demands.
• Willingness to travel up to 40%, including domestic field travel and periodic international travel to EU/UK markets.

Desirable Experience:

• Experience with EU, UK (NHS), and/or Irish (HSE) reimbursement and HTA frameworks.
• Background in neurology, stroke, dysphagia, or adjacent therapeutic areas.
• Experience engaging directly with CMS, MedPAC, or equivalent payer/HTA bodies.
• Familiarity with NTAP and new technology coverage pathways in the US hospital inpatient setting.

Skills & Capabilities

• A builder — energised by creating structure where none exists, not maintaining what is already in place.
• Strategically fluent and execution-oriented — able to move between high-level strategic framing and ground-level customer support without losing focus.
• Deeply collaborative — this role succeeds through partnership with CMRA, Medical Affairs, Marketing, and the field, not in isolation.
• Mission-driven — motivated by the fact that what you build directly determines whether stroke survivors can access a therapy that restores function and changes lives.